On Friday, Following U.S. Stocks were among the “Top Gainers”: Aetna Inc. (NYSE:AET), Halozyme Therapeutics, Inc. (NASDAQ:HALO), Cabela’s Incorporated (NYSE:CAB), Oracle Corporation (NYSE:ORCL)
Aetna Inc. (NYSE:AET), with shares inclined 1.93%, closed at $104.09.
Halozyme Therapeutics, Inc. (NASDAQ:HALO), with shares jumped 1.92%, settled at $15.93, hitting new 52-week high of $16.29.
Cabela’s Incorporated (NYSE:CAB), with shares climbed 1.86%, and closed at $57.50.
Oracle Corporation (NYSE:ORCL), surged 1.83%, and closed at $42.38.
Latest NEWS regarding these Stocks are depicted underneath:
Aetna Inc. (NYSE:AET)
Formerly on March 5, HealthCare USA of Missouri, an Aetna Inc. (AET), health plan that administers managed Medicaid services for MO HealthNet, has been selected by the Missouri Office of Administration, Division of Purchasing and Materials Administration, to continue to provide access to health care for eligible Missourians. The new three-year contract is planned to take effect July 1, 2015.
HealthCare USA, which has served MO HealthNet Managed Care beneficiaries for 20 years, was one of three managed care organizations selected to continue to serve the 430,000 Missourians who receive benefits through MO HealthNet. Brian Dobbins is chief executive officer of the health plan.
Aetna Inc. operates as a health care benefits corporation in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna Medicaid has more than 28 years of experience in providing access to health care services for the most medically vulnerable. Aetna serves more than 3.2 million Medicaid recipients in 17 states.
Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Halozyme Therapeutics, Inc. (HALO), stated that Genmab A/S declared plans for a Phase 1 clinical trial of a subcutaneous formulation of the anti-CD38 antibody daratumumab using the ENHANZE™ technology. In December 2014, Janssen Biotech, Inc. (Janssen) reached an contract with Halozyme Therapeutics for the purpose of developing and commercializing products combining proprietary Janssen compounds with Halozyme’s ENHANZE technology. This contract has the potential to lead to the development of a subcutaneous formulation of daratumumab. Daratumumab is being developed under a partnership between Janssen and Genmab A/S since August 2012 when Genmab granted Janssen an exclusive worldwide license to develop, manufacture, and commercialize daratumumab.
Daratumumab, a human monoclonal antibody that targets CD38 on the surface of multiple myeloma cells, is in clinical development as a single agent and in combination with standard of care therapies in several settings of multiple myeloma. Daratumumab may also have potential in other hematologic malignancies in which CD38 is expressed, counting non-Hodgkins lymphoma and various leukemias.
ENHANZE™ is Halozyme’s proprietary drug delivery platform based on the Corporation’s patented recombinant human hyaluronidase enzyme (rHuPH20). rHuPH20 has been shown to remove traditional limitations on the volume of biologics that can be delivered subcutaneously (just under the skin). By using rHuPH20, some biologics and compounds that are administered intravenously may instead be delivered subcutaneously.
Halozyme Therapeutics is a biotechnology corporation focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. Halozyme’s lead proprietary program, our investigational drug PEGPH20, applies a unique approach to targeting solid tumors, allowing raised access of co-administered cancer drug therapies to the tumor.
Cabela’s Incorporated (NYSE:CAB)
Cabela’s Incorporated (CAB), the World’s Foremost Outfitter® of hunting, fishing and outdoor gear, declared plans to bring the corporation’s unique retail experience and legendary customer service to Centerville, Ohio, and the greater Dayton area.
Construction on the 70,000-square-foot store is planned to start in 2015, and Cabela’s anticipates a spring 2016 opening. It will be located in the Cornerstone at Centerville development off Exit 7 of Interstate 675 near Wilmington Pike. Oberer Development Corporation is the developer.
Cabela’s anticipates to employ about 160 full-time, part-time and seasonal employees at the store, most of whom will come from Centerville and the surrounding area. Upon opening, it will become Cabela’s third retail location in Ohio, joining the 80,000-square-foot Columbus store opened in 2013 and the 80,000-square-foot West Chester location plan to open this fall.
The store will be built in Cabela’s new-format layout, designed to offer customers an enjoyable, outdoor-like experience with log construction, stonework, wood siding, a large mountain replica, an aquarium and dozens of museum-quality wildlife displays.
In addition to thousands of quality outdoor products, the store will comprise an indoor archery range and archery tech room, Gun Library, Bargain Cave, deli and fudge shop. Additionally, the store’s staff will host educational seminars and demonstrations, offering tips and insight on outdoor products and activities.
Cabela’s Incorporated, together with its auxiliaries, operates as a specialty retailer and direct marketer of hunting, fishing, camping, and related outdoor merchandise. Since the Corporation’s founding in 1961, Cabela’s® has grown to become one of the most well-known outdoor recreation brands in the world, and has long been recognized as the World’s Foremost Outfitter®.
Oracle Corporation (NYSE:ORCL)
To assist organizations efficiently reach, target and engage global consumers on social media channels, Oracle Corporation (ORCL), declared that Oracle Social Cloud’s Social Relationship Administration (SRM) platform now supports Instagram and Weibo. With the new capabilities, Oracle assists organizations deliver the best possible customer experience by adding two of the world’s fastest-growing social media platforms to the expanding lineup of social networks supported by the Oracle Social Cloud.
The social media landscape is continually expanding and has become increasingly fragmented. A recent study by Pew Research found that the number of online adults using two or more social channels raised from 42 percent in 2013 to 52 percent in 2014. This fragmented environment makes it more difficult than ever for organizations to gain a clear view of the customer and efficiently manage interactions across all social media channels.
With the new capabilities, Oracle Social Cloud will now provide engagement and analytics support for Instagram; and publishing, engagement and analytics support for Weibo. The addition of Instagram assists organizations leverage one of the fastest-growing social networks in the world to engage the coveted young adult category. The importance of images on social media has elevated Instagram’s popularity with more than half of internet-using young adults, ages 18-29, using the platform recently. Weibo is a highly popular social network that is used by more than 175.7 million Chinese consumers and 800,000 businesses connecting for communication, information, engagement and commerce.
Oracle Corporation develops, manufactures, markets, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
